International Cannabis Weekly: 245

FIRST SALES OF LEGAL ADULT-USE CANNABIS IN EUROPE DUE IN 2022

The first pilot project trial for the legalised sales of adult-use cannabis in Basel, Switzerland, was approved by the Swiss Government last week. This means that the first legal sales of adult-use cannabis in Europe since prohibition began will be achieved by late summer this year.

Public opinion has been gradually swaying towards favouring cannabis legalisation over the last few years. In Switzerland, over 65% of people ‘favour’ or ‘strongly favour’ cannabis legalisation.

Prohibition Partners explores the evolution of adult-use legalisation in Europe in depth in our recent Adult-Use Cannabis in Europe Report.

READ MORE »

PROHIBITION PARTNERS IS IN NEW YORK NEXT WEEK FOR REGENERATIVE CANNABIS LIVE

READ MORE »

THE UK FSA HAS EXTENDED THE DEADLINE FOR CBD APPLICATIONS

READ MORE »

• Since medical cannabis was legalised in 2020, 5,000 medical cannabis licences have been issued in Guernsey.
• Miracle Valley enters the German market via a new strategic partnership with Cantourage.
• Pure Holdings AG becomes the exclusive supplier of cannabis for a pilot scheme in Basel.
• Clever Leaves Germany becomes a fully licensed medical cannabis distributor with access to 20,000 pharmacies.
• Dr. Reddy’s strengthens its presence in Germany’s medical cannabis market after acquiring Nimbus Health.
• A court in Cologne confirms that even low levels of CBD are officially classed as a drug.
• A new high-cannabinoid-content variety has been added to the EU catalogue of common plant varieties.
• State of Mind Labs extends its bulk hemp offering by expanding with international shipping.
• Rangers Pharmaceutical announces that it has successfully established Europe’s first legal seedbank.
• Colombian firm Pideka SAS receives EU-GMP certification as it looks to export its raw cannabis flower.

CATCH UP ON THE CANNABIS IN EUROPE: MOVING WITH THE ZEITGEIST WEBINAR

Didn’t have time to join us for our live webinar this week? Catch up on all of the action from The European Cannabis Report: 7th Edition webinar, during which we discussed the trends driving the European cannabis industry forward, business opportunities, legislative momentum, forging a mainstream industry – and more.

Panellists included Barbara Pastori and Conor O’Brien from Prohibition Partners, and experts from The European Cannabis Report: 7th Editions sponsors, including: Roland Schneller, COO, Cansativa Group; Timo Bongartz, General Manager, Fluence EMEA; and Dr Florian Holzapfel, Co-Founder, Cantourage.

WATCH NOW »

• Joe Biden’s administration has granted clemency to people with cannabis convictions.
• When Georgia voters head to the ballots next month, they will get the chance to vote on cannabis legalisation.
• A new bill in California proposes to close loopholes enabling the ban of cannabis sales.
• A bill to legalise medical cannabis in Kansas could be passed this week as lawmakers are set to vote.
• A Kentucky governor has cleared the way for a cannabis research centre to open in the state.
• Panacea Life Sciences has signed an exclusive product manufacturing deal with Good Pharma.
• Ecofibre acquires hemp brand Soul Seed as it continues with its phase 3 study into sleep-related issues.

• Ikänik Farms closes C$3 million tranche of a C$6 million investment initiative to expand Pideka.
• Fire and Flower Q4 financial and operational revenue decreased by 6% to C$42.7million.
• Alberta is moving to develop infrastructure to support dual-cropping of hemp grain and fibre.
• RIV Capital completes acquisition of the non-regulated portion of New York-based Etain.
• The Victoria Cannabis Buyers Club has met with Health Canada to discuss dosage limits in cannabis products.
• Ayurcann Holdings Corp. announces that it has received its Flower Sales Licence from Health Canada.
• Vencanna Ventures has signed a definitive unit exchange agreement with Cannavative Group.

• The Supreme Court of Argentina is set to hold a hearing around the subject of cannabis self-cultivation.
• Zion Med Pharma has launched the first herbal medicine of cannabis sativa extract with CBD in Brazil.
• Cannava has begun harvesting 35 hectares of medical cannabis in the province of Jujuy.

• Nicaraguan president’s son proposes discussions on the legalisation of cannabis in the Central American country.

• Anvisa approves a new cannabis-based medicinal product in Brazil, the 15th with approval for marketing.

JOIN 500+ INDUSTRY LEADERS ACROSS TWO DAYS

DAY ONE | Conference – September 22, 2022
The New Capital of Cannabis
We will laser focus on New York and its surrounding states, with discussions on policy, investment, social equity and licensing – getting to grips with the key challenges facing this huge new market.

DAY TWO | Showcase & Summit – September 23, 2022
Cannabis Retail and Innovation
Alongside industry pioneers, we will look at the most exciting corner of the cannabis market in North America right now: retail – including the technology, innovation, design and data driving it forward.

SECURE YOUR SEAT »

• Las Vegas-based company Audacious opens a medical cannabis clinic in Thailand.
• Despite CBD products being legal in Australia, it’s likely that patients won’t have access to products until 2023.
• More than AU$5 million has been provided for an Australian medical cannabis research and training project.
• The Malaysian government has given the green light for the cultivation of cannabis for medical purposes.
• Heirs of the Phornprapha and Praneenij families are investing 120 million baht in launching Medicana Lab.

• Afriplex has entered the hemp market and launched a contract-grow model for small-scale farmers.
• Labat Africa has agreed a deal with the CSIR to grow and produce hemp at Coega in the Eastern Cape.
• The first South African medical cannabis dispensary has opened and will issue patients with access cards.
• The demand for medical cannabis from Israel is growing due to its competitive prices.
• WILD HEMP and Turning Point Brands partner with Cuban Connection to distribute to South Africa.
• Leafreport releases study details suggesting 60% of CBD sleep products contain the wrong amounts of CBD.